CVS Health Corporation filed a current report on November 4, 2026, disclosing its intention to separate into two independent, publicly traded companies in a transaction intended to be tax-free to the company and its shareholders for U.S. federal income tax purposes.

Key Highlights

  • Separation announced: CVS Health Corporation disclosed its intention to separate into two independent, publicly traded companies.
  • Tax treatment: The transaction is intended to be tax-free to the company and its shareholders for U.S. federal income tax purposes, according to the filing.
  • Disclosure mechanism: The announcement was made via a press release dated November 4, 2026, attached as Exhibit 99.1 and furnished under Regulation FD (Item 7.01).
  • Not "filed" for liability purposes: The information in Item 7.01, including Exhibit 99.1, "shall not be deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section."
  • Signatory: The report was signed by Kristina V. Fink, Senior Vice President, Corporate Secretary and Chief Governance Officer.

CVS Health Discloses Intent to Split Into Two Standalone Public Companies

On November 4, 2026, CVS Health Corporation (NYSE:CVS) filed an 8-K current report under Item 7.01 (Regulation FD Disclosure), announcing its intention to separate into two independent, publicly traded companies. According to the filing, the transaction is intended to be tax-free to the company and its shareholders for U.S. federal income tax purposes. The company did not provide further structural or operational details about the two entities within the body of the 8-K itself; additional information was contained in the attached press release (Exhibit 99.1).

The filing notes that the information disclosed under Item 7.01, including the press release, is furnished rather than filed, and accordingly "shall not be deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section." The filing also states the information "shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document."

CVS Health Corporation is incorporated in Delaware, headquartered at One CVS Drive, Woonsocket, Rhode Island 02895, and trades on the New York Stock Exchange under the symbol CVS. The report was signed by Kristina V. Fink, Senior Vice President, Corporate Secretary and Chief Governance Officer, on November 4, 2026. The filing contains forward-looking statements that are the company's own and are subject to its cautionary language as described in the press release incorporated by reference.

What Was Disclosed

CVS Health Corporation disclosed via an 8-K filed November 4, 2026, its intention to separate into two independent, publicly traded companies through a transaction intended to be tax-free for U.S. federal income tax purposes. The press release providing further detail was furnished as Exhibit 99.1.